Brief: Palatin Announces Presentation Of Positive Protective Effects Of PL8331 And PL9654 On Retinal Inflammation At 2021 American Society Of Retina Specialists Annual Meeting
27/09/2021 12:33
Sept 27 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN ANNOUNCES PRESENTATION OF POSITIVE PROTECTIVE
EFFECTS OF
PL8331 AND PL9654 ON RETINAL INFLAMMATION AT THE 2021 AMERICAN
SOCIETY OF RETINA SPECIALISTS (ASRS) ANNUAL MEETING
Source text for Eikon: ID:nPn416MNKa
Further company coverage: PTN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity